Interaction between SNCA, LRRK2 and GAK increases susceptibility to Parkinson's disease in a Chinese population

de Lau, 2006, Epidemiology of Parkinson's disease, Lancet Neurol., 5, 525, 10.1016/S1474-4422(06)70471-9 Braak, 2003, Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol. Aging, 24, 197, 10.1016/S0197-4580(02)00065-9 Nalls, 2014, Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease, Nat. Genet., 46, 989, 10.1038/ng.3043 Polymeropoulos, 1997, Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, 276, 2045, 10.1126/science.276.5321.2045 Spillantini, 1997, a-Synuclein in Lewy bodies, Nature, 388, 839, 10.1038/42166 Goedert, 2001, Alpha-synuclein and neurodegenerative diseases, Nat. Rev. Neurosci., 2, 492, 10.1038/35081564 Goris, 2007, Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease, Ann. Neurol., 62, 145, 10.1002/ana.21192 Mamah, 2005, Interaction of alpha-synuclein and tau genotypes in Parkinson's disease, Ann. Neurol., 57, 439, 10.1002/ana.20387 Trotta, 2012, SNCA and MAPT genes: independent and joint effects in Parkinson disease in the Italian population, Parkinsonism Relat. Disord., 18, 257, 10.1016/j.parkreldis.2011.10.014 Wider, 2011, SNCA, MAPT, and GSK3B in Parkinson disease: a gene–gene interaction study, Eur. J. Neurol., 18, 876, 10.1111/j.1468-1331.2010.03297.x Alegre-Abarrategui, 2008, LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease, Neuropathol. Appl. Neurobiol., 34, 272, 10.1111/j.1365-2990.2007.00888.x Guerreiro, 2012, LRRK2 interactions with alpha-synuclein in Parkinson's disease brains and in cell models, J. Mol. Med., 91, 513, 10.1007/s00109-012-0984-y Taymans, 2010, Mechanisms in dominant parkinsonism: the toxic triangle of LRRK2, a-synuclein, and tau, BioEssays, 32, 227, 10.1002/bies.200900163 Wang, 2012, Penetrance of LRRK2 G2385R and R1628P is modified by common PD associated genetic variants, Parkinsonism Relat. Disord., 18, 958, 10.1016/j.parkreldis.2012.05.003 Gru¨nblatt, 2004, Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes, J. Neural Transm., 111, 1543, 10.1007/s00702-004-0212-1 Dumitriu, 2011, Cyclin-G-associated kinase modifies a-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study, Hum. Mol. Genet., 20, 1478, 10.1093/hmg/ddr026 Beilina, 2014, Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease, Proc. Natl. Acad. Sci. U. S. A., 111, 2626, 10.1073/pnas.1318306111 Ritchie, 2001, Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer, Am. J. Hum. Genet., 69, 138, 10.1086/321276 Hahn, 2003, Multifactor dimensionality reduction software for detecting gene–gene and gene–environment interactions, Bioinformatics, 19, 376, 10.1093/bioinformatics/btf869 Li, 2013, SNCA rs356219 variant increases risk of sporadic Parkinson's disease in ethnic Chinese, Am. J. Med. Genet. B Neuropsychiatr. Genet., 162, 452, 10.1002/ajmg.b.32143 Li, 2012, GWAS-linked GAK locus in Parkinson's disease in Han Chinese and meta-analysis, Hum. Genet., 131, 1089, 10.1007/s00439-011-1133-3 Chang, 2011, Association of GWAS loci with PD in China, Am. J. Med. Genet. B Neuropsychiatr. Genet., 156, 334, 10.1002/ajmg.b.31167 Hughes, 1992, Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases, Journal of Neurology. Neurosurgery, and Psychiatry, 55, 181, 10.1136/jnnp.55.3.181 Arima, 1999, Cellular colocalization of phosphorylated tau- and NACP/[alpha]-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies, Brain Res., 843, 53, 10.1016/S0006-8993(99)01848-X Giasson, 2003, Initiation and synergistic fibrillization of tau and alpha-synuclein, Science, 300, 636, 10.1126/science.1082324 Carballo-Carbajal, 2010, Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway, Cell. Signal., 22, 821, 10.1016/j.cellsig.2010.01.006 Tong, 2010, Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice, Proc. Natl. Acad. Sci. U. S. A., 107, 9879, 10.1073/pnas.1004676107 Kondo, 2011, Alpha-synuclein aggregation and transmission are enhanced by leucine-rich repeat kinase 2 in human neuroblastoma SH-SY5Y cells, Biol. Pharm. Bull., 34, 1078, 10.1248/bpb.34.1078 Gandhi, 2008, The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules, J. Neurosci. Res., 86, 1711, 10.1002/jnr.21622 Joanna, 2011, Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?, Parkinsonism Relat. Disord., 17, 730, 10.1016/j.parkreldis.2011.07.001 Dan, 2014, MAPT IVS1þ124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals, Neurobiol. Aging, 35, 1780.e7, 10.1016/j.neurobiolaging.2014.01.025 Heckman, 2014, The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants, Neurobiol. Aging, 35, 266.e5, 10.1016/j.neurobiolaging.2013.07.013 Kimura, 1997, Structure, expression, and chromosomal localization of human GAK, Genomics, 44, 179, 10.1006/geno.1997.4873 Kanaoka, 1997, GAK: a cyclin G associated kinase contains a tensin/auxilin-like domain, FEBS Lett., 402, 73, 10.1016/S0014-5793(96)01484-6 Cullen, 2009, Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo, Mol. Brain, 9, 2